Kairos Pharma Ltd.

1.73
-0.04 (-2.26%)
At close: Jan 17, 2025, 3:59 PM
1.73
0.00%
After-hours Jan 17, 2025, 06:30 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -1.81M -1.05M -2.15M -1.05M
Depreciation & Amortization 160.00K 160.00K 98.00K n/a
Stock-Based Compensation 913.00K n/a 300.00K 800.00K
Other Working Capital 764.00K 129.00K 1.19M 212.82K
Other Non-Cash Items 56.00K 408.00K 144.00K n/a
Deferred Income Tax n/a n/a n/a n/a
Change in Working Capital 764.00K 129.00K 1.19M 212.82K
Operating Cash Flow 81.00K -353.00K -412.00K -38.53K
Capital Expenditures n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a
Other Investing Acitivies n/a n/a -109.00K n/a
Investing Cash Flow n/a n/a -109.00K n/a
Debt Repayment n/a 895.00K 330.00K 50.00K
Common Stock Repurchased n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a
Other Financial Acitivies -425.00K -178.00K n/a -13.00K
Financial Cash Flow -425.00K 717.00K 580.00K 37.00K
Net Cash Flow -344.00K 364.00K 59.00K -1.53K
Free Cash Flow 81.00K -353.00K -412.00K -38.53K